{
    "root": "c8178883-9da2-4b4f-88ee-182d628a2e41",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "Quetiapine fumarate"
    },
    "value": "20250303",
    "ingredients": [
        {
            "name": "QUETIAPINE FUMARATE",
            "code": "2S3PL1B6UJ"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "POLYETHYLENE GLYCOL 4000",
            "code": "4R4HFI6D95"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "indications": "quetiapine atypical antipsychotic indicated treatment : schizophrenia ( 1.1 ) bipolar disorder manic episodes ( 1.2 ) bipolar disorder , depressive episodes ( 1.2 )",
    "contraindications": "quetiapine tablets taken without food ( 2.1 ) indication initial dose recommended dose maximum dose schizophrenia-adults ( 2.2 ) 25 mg twice daily 150 750 mg/day 750 mg/day schizophrenia-adolescents ( 13 17 years ) ( 2.2 ) 25 mg twice daily 400 800 mg/day 800 mg/day bipolar mania- adults monotherapy adjunct lithium divalproex ( 2.2 ) 50 mg twice daily 400 800 mg/day 800 mg/day bipolar mania- children adolescents ( 10 17 years ) , monotherapy ( 2.2 ) 25 mg twice daily 400 600 mg/day 600 mg/day bipolar depression-adults ( 2.2 ) 50 mg daily bedtime 300 mg/day 300 mg/day geriatric : consider lower starting dose ( 50 mg/day ) , slower titration careful monitoring initial dosing period elderly ( 2.3 , 8.5 ) hepatic impairment : lower starting dose ( 25 mg/day ) slower titration may needed ( 2.4 , 8.7 , 12.3 )",
    "warningsAndPrecautions": "25 mg tablets peach , round , biconvex , film-coated tablets , debossed '25 ' one side plain side supplied : bottles 30 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-902-83 bottles 100 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-902-88 bottles 1000. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-902-18 unit-dose blister pack 100 ( 10 \u00d7 10 ) tablets . . . . . . . . . . . . ndc 47335-902-61 50 mg tablets white , round , biconvex , film-coated tablets , debossed '50 ' one side plain side supplied : bottles 30 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-903-83 bottles 100 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-903-88 bottles 1000. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-903-18 unit-dose blister pack 100 ( 10 \u00d7 10 ) tablets . . . . . . . . . . . ndc 47335-903-61 100 mg tablets yellow , round , biconvex , film-coated tablets , debossed '904 ' one side plain side supplied : bottles 30 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-904-83 bottles 100 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-904-88 bottles 1000. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-904-18 unit-dose blister pack 100 ( 10 \u00d7 10 ) tablets . . . . . . . . . . . ndc 47335-904-61 200 mg tablets white , round , biconvex , film-coated tablets , debossed '905 ' one side plain side supplied : bottles 30 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-905-83 bottles 100 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-905-88 bottles 1000. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-905-18 unit-dose blister pack 100 ( 10 \u00d7 10 ) tablets . . . . . . . . . . . ndc 47335-905-61 300 mg tablets white , capsule-shaped , biconvex , film-coated tablets , debossed '906 ' one side plain side supplied : bottles 30 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-906-83 bottles 60 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-906-86 bottles 100 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-906-88 bottles 1000. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-906-18 unit-dose blister pack 100 ( 10 \u00d7 10 ) tablets . . . . . . . . . . . ndc 47335-906-61 400 mg tablets yellow , capsule-shaped , biconvex , film-coated tablets , debossed '907 ' one side plain side supplied : bottles 30 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-907-83 bottles 100 child-resistant cap . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-907-88 bottles 1000. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ndc 47335-907-18 unit-dose blister pack 100 ( 10 \u00d7 10 ) tablets . . . . . . . . . . . ndc 47335-907-61 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "hypersensitivity quetiapine excipients quetiapine formulation . anaphylactic reported patients treated quetiapine .",
    "indications_original": "Quetiapine is an\u00a0atypical antipsychotic indicated for the treatment of: Schizophrenia ( 1.1 ) Bipolar I disorder manic episodes ( 1.2 ) Bipolar disorder, depressive episodes ( 1.2 )",
    "contraindications_original": "Quetiapine tablets can be taken with or without food ( 2.1 ) Indication Initial Dose Recommended Dose Maximum Dose Schizophrenia-Adults ( 2.2 ) 25 mg twice daily 150 to 750 mg/day 750 mg/day Schizophrenia-Adolescents (13 to 17 years) ( 2.2 ) 25 mg twice daily 400 to 800 mg/day 800 mg/day Bipolar Mania- Adults Monotherapy or as an adjunct to lithium or divalproex ( 2.2 ) 50 mg twice daily 400 to \u00a0800 mg/day 800 mg/day Bipolar Mania- Children and Adolescents (10 to 17 years), Monotherapy ( 2.2 ) 25 mg twice daily 400 to 600 mg/day 600 mg/day Bipolar Depression-Adults ( 2.2 ) 50 mg once daily at bedtime 300 mg/day 300 mg/day Geriatric Use: Consider a lower starting dose (50 mg/day), slower titration and careful monitoring during the initial dosing period in the elderly ( 2.3 , 8.5 ) Hepatic Impairment: Lower starting dose (25 mg/day) and slower titration may be needed ( 2.4 , 8.7 , 12.3 )",
    "warningsAndPrecautions_original": "25 mg tablets are peach, round, biconvex, film-coated tablets, debossed with '25' on one side and plain on the other side and are supplied as:\n                  Bottles of 30 with child-resistant cap...........................NDC 47335-902-83\n                  Bottles of 100\u00a0with child-resistant cap.........................NDC 47335-902-88\n                  Bottles of 1000.............................................................NDC 47335-902-18\n                  Unit-dose blister pack of 100 (10 \u00d7 10) tablets............NDC 47335-902-61\n                      50 mg tablets are white, round, biconvex, film-coated tablets, debossed with '50' on one side and plain on the other side and are supplied as:\n                  Bottles of 30 with child-resistant cap...........................NDC 47335-903-83\n                  Bottles of 100\u00a0with child-resistant cap.........................NDC 47335-903-88\n                  Bottles of 1000............................................................NDC 47335-903-18\n                  Unit-dose blister pack of 100 (10 \u00d7 10) tablets...........NDC 47335-903-61\n                  \n                  100 mg tablets are yellow, round, biconvex, film-coated tablets, debossed with '904' on one side and plain on the other side and are supplied as:\n                  Bottles of 30 with child-resistant cap...........................NDC 47335-904-83\n                  Bottles of 100\u00a0with child-resistant cap.........................NDC 47335-904-88\n                  Bottles of 1000............................................................NDC 47335-904-18\n                  Unit-dose blister pack of 100 (10 \u00d7 10) tablets...........NDC 47335-904-61\n                      200 mg tablets are white, round, biconvex, film-coated tablets, debossed with '905' on one side and plain on the other side and are supplied as:\n                  Bottles of 30 with child-resistant cap...........................NDC 47335-905-83\n                  Bottles of 100\u00a0with child-resistant cap ........................NDC 47335-905-88\n                  Bottles of 1000............................................................NDC 47335-905-18\n                  Unit-dose blister pack of 100 (10 \u00d7 10) tablets...........NDC 47335-905-61\n                      300 mg tablets are white, capsule-shaped, biconvex, film-coated tablets, debossed with '906' on one side and plain on the other side and are supplied as:\n                  Bottles of 30 with child-resistant cap...........................NDC 47335-906-83\n                  Bottles of 60 with child-resistant cap...........................NDC 47335-906-86\n                  Bottles of 100\u00a0with child-resistant cap.........................NDC 47335-906-88\n                  Bottles of 1000............................................................NDC 47335-906-18\n                  Unit-dose blister pack of 100 (10 \u00d7 10) tablets...........NDC 47335-906-61\n                      400 mg tablets are yellow, capsule-shaped, biconvex, film-coated tablets, debossed with '907' on one side and plain on the other side and are supplied as:\n                  Bottles of 30 with child-resistant cap...........................NDC 47335-907-83\n                  Bottles of 100\u00a0with child-resistant cap.........................NDC 47335-907-88\n                  Bottles of 1000............................................................NDC 47335-907-18\n                  Unit-dose blister pack of 100 (10 \u00d7 10) tablets...........NDC 47335-907-61\n                      Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted between 15\u00b0 and 30\u00b0C (59\u00b0 and 86\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Hypersensitivity to quetiapine or to any excipients in the quetiapine formulation. Anaphylactic reactions have been reported in patients treated with quetiapine."
}